Cboe BZX · XSHQ
Invesco S&P SmallCap Quality ETF financials
$45.22−0.81%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 |
|---|---|---|---|---|
| Revenue | $6.89B | $6.15B | $6.12B | $5.31B |
| Gross profit | $6.89B | $6.15B | $6.12B | $5.31B |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating income | $1.79B | $920.4M | $808.2M | $1.34B |
| Net income | $1.39B | $524.8M | $564.7M | $882.8M |
| Net margin | 20.2% | 8.5% | 9.2% | 16.6% |
| Diluted EPS | $2.99 | $1.13 | $1.28 | $2.14 |
| EBITDA | $1.93B | $1.45B | $1.61B | $1.48B |
| Operating cash flow | $1.41B | $1.02B | $1.16B | $1.22B |
| Free cash flow | $1.30B | $900.4M | $1.04B | $1.11B |
| Diluted shares | 465.4M | 462.5M | 440.5M | 412.5M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Cash & equivalents | $2.15B | $1.71B | $1.70B | $1.81B |
| Short-term investments | $9.97B | $8.74B | $8.64B | $6.83B |
| Total debt | $9.42B | $8.90B | $8.47B | $7.81B |
| Total assets | $32.69B | $36.50B | $39.42B | $30.98B |
| Total liabilities | $16.01B | $21.48B | $24.72B | $21.65B |
| Shareholders' equity | $16.17B | $14.81B | $14.32B | $8.94B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology